000 01256 a2200337 4500
005 20250515043233.0
264 0 _c20061113
008 200611s 0 0 eng d
022 _a1524-4539
024 7 _a10.1161/CIRCULATIONAHA.106.624320
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, Ken W
245 0 0 _aPirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure.
_h[electronic resource]
260 _bCirculation
_cOct 2006
300 _a1703-12 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aDisease Models, Animal
650 0 4 _aDogs
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aPyridones
_xtherapeutic use
700 1 _aEverett, Thomas H
700 1 _aRahmutula, Dulkon
700 1 _aGuerra, Jose M
700 1 _aWilson, Emily
700 1 _aDing, Chunhua
700 1 _aOlgin, Jeffrey E
773 0 _tCirculation
_gvol. 114
_gno. 16
_gp. 1703-12
856 4 0 _uhttps://doi.org/10.1161/CIRCULATIONAHA.106.624320
_zAvailable from publisher's website
999 _c16607296
_d16607296